Jon S. Saxe, Director at PDL BIOPHARMA, INC. (PDLI), sold 5,000 shares at $32.01 ($160K) on 2006-03-29, disclosed to the SEC on 2006-03-31.
Scheduled sale ($160k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.00 | 4,642 | $149K | 92.8% |
| 2 | $32.01 | 358 | $11K | 7.2% |
| Total | $32.00 avg | 5,000 | $160K | 100% |
| Filing → |
| DRRX | BUY | 2019-05-28 | $19K | — | Filing → |
| DRRX | BUY | 2019-05-15 | $7K | — | Filing → |
| DRRX | BUY | 2019-05-14 | $55K | — | Filing → |